UT Southwestern Medical Center will lead a national multicenter clinical trial to test a treatment strategy for pediatric cancer patients that has shown promising results in adults. The trial will examine the effects of combining several chemotherapy agents with an immunotherapy drug in children with solid tumors that have recurred or shown no significant response after initial treatment.
Newswise: Latest News
charmdate review
April 24, 2023By
Parents, students call for safety review in wake of deadly school shooting
April 15, 2022By
Parents and students called for greater safety measures and transparency at the Michigan high school where four students were fatally shot in a mass shooting last year.
ABC News: Top Stories
FDA: Merck COVID pill effective, experts will review safety
November 26, 2021By
U.S. health officials say Merck’s experimental COVID-19 pill is effective but they raised questions about its safety during pregnancy
ABC News: Top Stories
Review indicates mental health ‘resilience’ rather than crisis during COVID-19 pandemic
October 31, 2021By
Despite a significant but small increase in mental health symptoms early on in the COVID-19 pandemic, overall there was great resilience in mental health during 2020, University of Liverpool researchers have found.
Newswise: Latest News
Patent court to review Alexion’s Soliris patents on Amgen challenge
September 2, 2019By
The U.S. patent office will review patents on Alexion Pharmaceuticals Inc’s blood disorder treatment Soliris, after Amgen Inc challenged them, court filings showed on Friday.
Review: Architecture and sculpture in perfect union at the Schindler House
November 17, 2018By
Conversations among prominent writers, musicians, architects and dancers have taken place in the Schindler House since it was built in 1921-22. Edmund de Waal’s installation on view there now makes deeply stirring conversation with the house.
R.M. Schindler, an emigré from Vienna, crafted on the…
U.S. FDA releases initial review of Philip Morris’ iQOS device
January 22, 2018By
(Reuters) – An electronic product made by Philip Morris International Inc that heats rather than burns tobacco contains lower levels of harmful and potentially harmful compounds than cigarettes, a preliminary review by the U.S. Food and Drug Administration (FDA) concluded on Monday.
Roche says FDA grants priority review for Actemra
January 24, 2017By
ZURICH (Reuters) – The U.S. Food and Drug Administration (FDA) has granted priority review designation of Roche’s rheumatoid arthritis medication Actemra for giant cell arteritis (GCA), the Swiss drugmaker said on Tuesday.
Nutrition data review shows red meat has neutral effect on cardiovascular disease risk factors
December 20, 2016By
Consuming red meat in amounts above what is typically recommended does not affect short-term cardiovascular disease risk factors, such as blood pressure and blood cholesterol, according to a new review.
Latest Science News — ScienceDaily
